These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9691098)

  • 1. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
    Meyer C; Stumvoll M; Nadkarni V; Dostou J; Mitrakou A; Gerich J
    J Clin Invest; 1998 Aug; 102(3):619-24. PubMed ID: 9691098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.
    Woerle HJ; Popa E; Dostou J; Welle S; Gerich J; Meyer C
    Metabolism; 2002 Nov; 51(11):1494-500. PubMed ID: 12404204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.
    Meyer C; Woerle HJ; Dostou JM; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1049-56. PubMed ID: 15304374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C; Tolias A; Platanisiotis D; Stumvoll M; Vlachos L; Mitrakou A
    Diabet Med; 2005 Apr; 22(4):453-9. PubMed ID: 15787672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity.
    Woerle HJ; Meyer C; Popa EM; Cryer PE; Gerich JE
    Diabetes; 2003 Jun; 52(6):1386-92. PubMed ID: 12765948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in basal glucose metabolism during late pregnancy in the conscious dog.
    Connolly CC; Holste LC; Aglione LN; Neal DW; Lacy DB; Smith MS; Diamond MP; Cherrington AD; Chiasson JL
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1166-77. PubMed ID: 11052973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
    Woerle HJ; Szoke E; Meyer C; Dostou JM; Wittlin SD; Gosmanov NR; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E67-E77. PubMed ID: 16105859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism.
    Meyer C; Dostou J; Nadkarni V; Gerich J
    Am J Physiol; 1998 Dec; 275(6):F915-21. PubMed ID: 9843908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
    Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
    J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine and alanine metabolism in NIDDM.
    Stumvoll M; Perriello G; Nurjhan N; Bucci A; Welle S; Jansson PA; Dailey G; Bier D; Jenssen T; Gerich J
    Diabetes; 1996 Jul; 45(7):863-8. PubMed ID: 8666134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of splanchnic and renal substrate supply by insulin in humans.
    Cersosimo E; Garlick P; Ferretti J
    Metabolism; 2000 May; 49(5):676-83. PubMed ID: 10831183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans.
    Meyer C; Stumvoll M; Dostou J; Welle S; Haymond M; Gerich J
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E428-34. PubMed ID: 11788376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
    Consoli A; Nurjhan N; Capani F; Gerich J
    Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
    Boden G; Chen X; Capulong E; Mozzoli M
    Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans.
    Meyer C; Stumvoll M; Welle S; Woerle HJ; Haymond M; Gerich J
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E819-26. PubMed ID: 12959936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes.
    Cersosimo E; Garlick P; Ferretti J
    Diabetes; 2001 Sep; 50(9):2087-93. PubMed ID: 11522675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.